Over the past decade, the sold production of vaccines for veterinary medicine in Germany has shown fluctuating trends. Between 2013 and 2023, production values varied, with significant increases in 2014 (19.55%) and 2020 (24.43%), contrasting with notable declines in 2015 (-16.44%) and 2019 (-22.43%). The overall Compound Annual Growth Rate (CAGR) from 2013 to 2023 stands at approximately 1%.
For the recent two years leading up to 2023, the year-on-year variations were moderate, with value increases of 3.07% in 2022 and 3.02% in 2023, indicating relative stability. The 5-year CAGR leading to 2023 was around 1%, signaling a slow growth trend.
Looking forward from 2024 onwards, forecasted data suggests a steady increase in production value. By 2028, the expected 5-year CAGR is 2.11%, projecting an overall growth rate of 10.99% from 2024 to 2028. This forecast indicates a more consistent upward trend in the production of veterinary vaccines in Germany.
Future trends to watch for include potential influences of new technological advancements in vaccine development, changing regulatory environments, and shifts in livestock disease patterns. Enhanced focus on animal health and the increasing adoption of vaccination programs could further drive production growth.
